# A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

> **NCT00111631** · PHASE2 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 218 (actual)

## Conditions studied

- Diabetes Mellitus Type 2

## Interventions

- **DRUG:** DPP-IV Inhibitor
- **DRUG:** Metformin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00111631
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2006-10
- **Final completion:** 2006-10
- **Target enrollment:** 218 (ACTUAL)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00111631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00111631, "A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00111631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*